ProPhase Labs (PRPH) Return on Equity [ROE] (2011 - 2026)
ProPhase Labs (PRPH) recorded Return on Equity [ROE] of -1554.44% in Q1 2026, down 1170.54 percentage points from -383.90% a year earlier and down 1270.08 percentage points from the prior quarter.
Powered by 
Analysis
ProPhase Labs (PRPH) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, ProPhase Labs reported Return on Equity [ROE] of -271.49%, down 83.37 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three straight years, with a five-year change of -251.98 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -188.11% in FY2024 (-158.41 pp), -29.70% in FY2023 (-59.90 pp), 30.20% in FY2022 (+12.07 pp) and 18.13% in FY2021 (+37.64 pp).
- The Q1 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q3 2011.
- On a year-over-year basis, Return on Equity [ROE] has declined for 13 consecutive quarters, with an average year-over-year change of -312.66 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 57.32 percentage points in Q3 2022, against a drop of 1170.54 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -284.37% (Q4 2025), -455.86% (Q3 2025) and -312.21% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | ProPhase Labs | 155,925.56 | -390,074.44 | 226,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -1,554.44% |
| Dec 31, 2025 | -284.37% |
| Sep 30, 2025 | -455.86% |
| Jun 30, 2025 | -312.21% |
| Mar 31, 2025 | -383.90% |
| Dec 31, 2024 | -234.68% |
| Sep 30, 2024 | -66.55% |
| Jun 30, 2024 | -58.26% |
| Mar 31, 2024 | -49.22% |
| Dec 31, 2023 | -30.96% |
| Sep 30, 2023 | -18.11% |
| Jun 30, 2023 | -7.33% |
| Mar 31, 2023 | 10.55% |
| Dec 31, 2022 | 28.07% |
| Sep 30, 2022 | 46.29% |
| Jun 30, 2022 | 39.45% |
| Mar 31, 2022 | 28.32% |
| Dec 31, 2021 | 11.74% |
| Sep 30, 2021 | -11.03% |
| Jun 30, 2021 | -3.43% |
API Access
ProPhase Labs Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PRPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();